Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions. Colocalization of myeloperoxidase and hypochlorite-modified proteins

European Journal of Biochemistry

Volumn 267, Issue 14, 2000, Pages 4495-4503

  Malle, Ernst ^b   Waeg, Georg ^c   Schreiber, Renate ^c   Gröne, Elisabeth F ^a   Sattler, Wolfgang ^c   Gröne, Hermann Josef ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c NONE

Author keywords

Atherogenesis; Inflammation; Oxidized lipoproteins

Indexed keywords

HALIDE; HYDROGEN PEROXIDE; MYELOPEROXIDASE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; FATTY ACID OXIDATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGED; ANTIBODIES, MONOCLONAL; AORTA; ARTERIOSCLEROSIS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FEMORAL ARTERY; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXYGEN; PEROXIDASE; TIBIAL ARTERIES; ULTRACENTRIFUGATION;

EID: 0001059250     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01498.x     Document Type: Article

References (58)

1. 1. Berliner, J.A. & Heinecke, J.W. (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707-727.
2. 2. Steinberg, D. (1997) Oxidative modification of LDL and atherogenesis. Circulation 95, 1062-1071.
3. 3. Cox, D.A. & Cohen, M.L. (1996) Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications of atherosclerosis. Pharmacol. Rev. 48, 3-19.
4. 4. Suarna, C., Dean, R.T., May, J. & Stocker, R. (1995) Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15, 1616-1624.
5. 5. Rosenfeld, M.E., Palinski, W., Ylä-Herttuala, S., Butler, S. & Witztum, J.L. (1990) Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10, 336-349.
6. 6. Palinski, W., Rosenfeld, M.E., Ylä-Herttuala, S., Gurtner, G.C., Socher, S.S., Butler, S.W., Parthasarathy, S., Carew, T.E., Steinberg, D. & Witztum, J.L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl Acad. Sci. USA 86, 1372-1376.
7. 7. Regnstrom, J. & Nilsson, J. (1994) Lipid oxidation and inflammation-induced intimal fibrosis in coronary heart disease. J. Lab. Clin. Med. 124, 162-168.
8. 8. Cochrane, C.G. (1991) Cellular injury by oxidants. Am. J. Med. 91 (3C), 23S-30S.
9. 9. Kettle, A.J. & Winterbourn, C.C. (1997) Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report 3, 3-15.
10. 10. Winterbourn, C.C. (1985) Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta 840, 204-210.
11. 11. Prütz, W.A. (1996) Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophys. 332, 110-120.
12. 12. Hazell, L.J. & Stocker, R. (1993) Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290, 165-172.
13. 13. Panzenboeck, U., Raitmayer, S., Reicher, H., Lindner, H., Glatter, O., Malle, E. & Sattler, W. (1997) Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J. Biol. Chem. 272, 29711-29720.
14. 14. Bergt, C., Reicher, H., Malle, E. & Sattler, W. (1999) Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages. FEBS Lett. 452, 295-300.
15. 15. Woenckhaus, C., Kaufmann, A., Bussfeld, D., Gemsa, D., Sprenger, H. & Gröne, H.J. (1998) Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes. Clin. Immunol. Immunopathol. 86, 27-33.
16. 16. Kopprasch, S., Leonhardt, W., Pietzsch, J. & Kuhne, H. (1998) Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis 136, 315-324.
17. 17. Opper, C., Schüssler, G., Sattler, W. & Malle, E. (1998) Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function. Platelets 9, 339-341.
18. 2+ -ATPase activity of human platelets. Cell Calcium 26, 281-287.
19. 19. Daugherty, A., Dunn, J.L., Rateri, D.L. & Heinecke, J.W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444.
20. 20. Malle, E., Woenckhaus, C., Waeg, G., Esterbauer, H., Gröne, E. & Gröne, H.J. (1997) Immunological evidence for hypochlorite-modified proteins in human kidney. Am. J. Pathol. 150, 603-615.
21. 21. Hazell, L.J., Arnold, L., Flowers, D., Waeg, G., Malle, E. & Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97, 1535-1544.
22. 22. Scheuer, H., Gwinner, W., Hohbach, J., Gröne, E.F., Brandes, R.P., Malle, E., Olbricht, C.J., Walli, A.K. & Gröne, H.-J. (2000) Oxidant stress in hyperlipidemia-induced renal damage. Am. J. Physiol. Renal Physiol. 278, F63-F74.
23. 23. Malle, E., Hazell, L., Stocker, R., Sattler, W., Esterbauer, H. & Waeg, G. (1995) Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler. Thromb. Vasc. Biol. 15, 982-989.
24. 24. Puhl, H., Waeg, G. & Esterbauer, H. (1994) Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 233, 425-441.
25. 25. Duell, P.B., Oram, J.F. & Bierman, E.L. (1991) Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes 40, 377-384.
26. 26. Balla, G., Jacob, H.S., Eaton, J.W., Belcher, J.D. & Vercellotti, G.M. (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11, 1700-1711.
27. 27. Pfeiffer, S., Gorren, A.C.F., Schmidt, K., Werner, E.R., Hansert, B., Bohle, D.S. & Mayer, B. (1997) Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2: 1 stoichiometry. J. Biol. Chem. 272, 3465-3470.
28. 28. Pfeiffer, S., Leopold, E., Hemmens, B., Schmidt, K., Werner, E.R. & Mayer, B. (1997) Interference of carboxy-PTIO with nitric oxide-and peroxynitrite-mediated reactions. Free Radic. Biol. Med. 22, 787-794.
29. 29. Hazen, S.L., Hsu, F.F., Mueller, D.M., Crowley, J.R. & Heinecke, J.W. (1996) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98, 1283-1289.
30. 30. Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W., Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D. & Wissler, R.W. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation 89, 2462-2478.
31. 31. Stary, H.C., Chandler, A.B., Dinsmore, R.E., Fuster, V., Glagov, S., Insull, W. Jr, Rosenfeld, M.E., Schwartz, C.J., Wagner, W.D. & Wissler, R.W. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15, 1512-1531.
32. 32. Hawkins, C.L. & Davies, M.J. (1999) Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation. Biochem. J. 340, 539-548.
33. 33. Grant, G.A. (1992) Synthetic Peptides, A User's Guide. Univerity of Wisconsin Biotechnology Center Madison, Wisconsin. UWBC Biotechnical Resource Series. W. H. Freeman, New York.
34. 34. Hazen, S.L. & Heinecke, J.W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atheroselerotic intima. J. Clin. Invest. 99, 2075-2081.
35. 35. Eiserich, J.P., Hristova, M., Cross, C.E., Jones, A.D., Freeman, B.A., Halliwell, B. & van der Vliet, A. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391, 393-397.
36. 36. Podrez, E.A., Schmitt, D., Hoff, H.F. & Hazen, S.L. (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103, 1547-1560.
37. 37. Hazen, S.L., Zhang, R., Shen, Z., Wu, W., Podrez, E.A., MacPherson, J.C., Schmitt, D., Mitra, S.N., Mukhopadhyay, C., Chen, Y., Cohen, P.A., Hoff, H.F. & Abu-Soud, H.M. (1999) Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes. Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85, 950-958.
38. 38. O'Brien, K.D., Alpers, C.E., Hokanson, J.E., Wang, S. & Chait, A. (1996) Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. Circulation 94, 1216-1225.
39. 39. Huxatable, R.J. (1992) Physiological actions of taurine. Physiol. Rev. 72, 101-163.
40. 40. Petty, M.A., Kintz, J. & DiFrancesco, G.F. (1990) The effects of taurine on atherosclerosis development in chlesterol-fed rabbits. Eur. J. Pharmacol. 180, 119-127.
41. 41. Murakami, S., Kondo, Y., Tomisawa, K. & Nagate, T. (1999) Prevention of atherosclerotic lesion development in mice by taurine. Drugs Exp. Clin. Res. 25, 227-234.
42. 42. Savenkova, M.L., Mueller, D.M. & Heinecke, J.W. (1994) Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269, 20394-20400.
43. 43. Schultz, J. & Kaminker, K. (1962) Myeloperoxidase of leukocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys. 96, 465-467.
44. 44. Tobler, A., Miller, C.W., Johnson, K.R., Selsted, M.E., Rovera, G. & Koeffler, H.P. (1988) Regulation of gene expression of myeloperoxidase during myeloid differentiation. J. Cell. Physiol. 136, 215-225.
45. 45. Nagra, R.M., Becher, B., Tourtellotte, W.W., Antel, J.P., Gold, D., Paladino, T., Smith, R.A., Nelson, J.R. & Reynolds, W.F. (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78, 97-107.
46. 46. Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R. A. & Masliah, E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155, 31-41.
47. 47. Schmekel, B., Hornblad, Y., Linden, M., Sundstrom, C. & Venge, P. (1990) Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages. Inflammation 14, 455-641.
48. 48. Shepherd, V.L. & Hoidal, J.R. (1990) Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell. Mol. Biol. 2, 335-340.
49. 49. Lefkowitz, D.L., Mills, K., Castro, A. & Lefkowitz, S.S. (1991) Induction of tumor necrosis factor and macrophage-mediated cytotoxicity by horseradish peroxidase and other glycosylated proteins: the role of enzymatic activity and LPS. J. Leukoc. Biol. 50, 615-623.
50. 50. Lefkowitz, D.L., Mills, K.C., Moguilevsky, N., Bollen, A., Vaz, A. & Lefkowitz, S.S. (1993) Regulation of macrophage function by human recombinant myeloperoxidase. Immunol. Lett. 36, 43-49.
51. 51. Lefkowitz, S.S., Gelderman, MR, Lefkowitz, D.L., Moguilevsky, N. & Bollen, A. (1996) Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J. Infect Dis. 173, 1202-1207.
52. 52. Mathy-Hartert, M., Deby-Dupont, G., Melin, P., Lamy, M. & Deby, C. (1996) Bacterial activity against Pseudomonas aeruginosa is aquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidase. Experientia 52, 167-174.
53. 53. Heifets, L., Imai, K. & Goren, M.B. (1980) Expression of peroxidase-dependent iodination by macrophages ingesting neutrophil debris. J. Reticulaendothel. Soc. 28, 391-404.
54. 54. Newman, S.L., Henson, J.E. & Henson, P.M. (1982) Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156, 430-442.
55. 55. Zabucchi, G., Soranzo, M.R., Menegazzi, R., Bertoncin, P., Nardon, E. & Patriarca, P. (1989) Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the inflammatory process. J. Histochem. Cytochem. 37, 499-508.
56. 56. Daphna, E.M., Michaela, S., Eynat, P., Irit, A. & Rimon, S. (1998) Association of myeloperoxidase with heparin: Oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol. Cell. Biochem. 183, 55-61.
57. 57. Tatsumi, T. & Fliss, H. (1994) Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am. J. Physiol. 267, H1597-H1607.
58. 58. Mathy-Hartert, M., Deby-Dupont, G., Deby, C., Jadoul, L., Vandenberghe, A. & Lamy, M. (1995) Cytotoxicily towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime. Med. Inflammation 4, 437-443.